ÖZKURT, Z. N. Et Al. 2023. DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?. 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , (ELECTR NETWORK), 484-485.

ÖZKURT, Z. N., YILDIZ, Ş., DEMİREZEN, A., YEGİN, Z. A., & YAĞCI, A. M., (2023). DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE? . 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (pp.484-485). , ELECTR NETWORK

ÖZKURT, ZÜBEYDE Et Al. "DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?," 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 2023

ÖZKURT, ZÜBEYDE N. Et Al. "DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?." 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , ELECTR NETWORK, pp.484-485, 2023

ÖZKURT, Z. N. Et Al. (2023) . "DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?." 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , ELECTR NETWORK, pp.484-485.

@conferencepaper{conferencepaper, author={ZÜBEYDE NUR ÖZKURT Et Al. }, title={DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?}, congress name={49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation}, city={}, country={ELECTR NETWORK}, year={2023}, pages={484-485} }